Share Name Share Symbol Market Type Share ISIN Share Description
Plant Impact LSE:PIM London Ordinary Share GB00B1F4K366 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -1.00p -2.22% 44.00p 43.00p 45.00p 45.00p 44.00p 45.00p 7,255.00 14:54:02
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Chemicals 7.2 -1.2 -0.9 - 35.95

Plant Impact (PIM) Latest News (1)

More Plant Impact News
Plant Impact Takeover Rumours

Plant Impact (PIM) Share Charts

1 Year Plant Impact Chart

1 Year Plant Impact Chart

1 Month Plant Impact Chart

1 Month Plant Impact Chart

Intraday Plant Impact Chart

Intraday Plant Impact Chart

Plant Impact (PIM) Discussions and Chat

Plant Impact Forums and Chat

Date Time Title Posts
03/12/201608:14Plant Impact - Increasing crop capacity935.00
14/5/201414:15PIM - Built on sand?4.00
17/9/201318:20PLANT IMPACT : transforming agriculture with eco-friendly solutions1,661.00
15/12/201108:26Plant Impact plc606.00
16/11/200611:26The way forwaard?......Pim's No 1 imho6.00

Add a New Thread

Plant Impact (PIM) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Plant Impact trades in real-time

Plant Impact (PIM) Top Chat Posts

DateSubject
03/12/2016
08:20
Plant Impact Daily Update: Plant Impact is listed in the Chemicals sector of the London Stock Exchange with ticker PIM. The last closing price for Plant Impact was 45p.
Plant Impact has a 4 week average price of 47.16p and a 12 week average price of 49.40p.
The 1 year high share price is 61p while the 1 year low share price is currently 43.50p.
There are currently 81,695,400 shares in issue and the average daily traded volume is 56,085 shares. The market capitalisation of Plant Impact is £35,945,976.
14/7/2016
08:02
horace_h: Looking at the "viciouscircle" posts, he/she was "the large shareholder that got out in June 2009 with a price he/she was happy with". That would be (at best) the 45p price that has prompted this re-appearance as the price has fallen back from last year's high of circa 65p. No surprise that he/she didn't appear at THAT point to say that he/she had been wrong and should have held. So what kind of keyboard warrior nurses that sort of six year old angst? What kind of warrior (groan) comes back after such a time to give an articulate damnation of Plant Impact from his/her point of view? In virtually the same style as Agextpert on an earlier insidious thread. Marks out of 10? I really don't care whether it is David Marks or not - if it is then he clearly hasn't learned anything from his dismissal in 2009 and one would wonder why HE doesn't stick with what he was clearly very good at. Corporations such as Bayer, Syngenta etc. do not form the type of relationship John Brubaker and David Jones have developed unless they are true professionals. Going back to making mischief in "chat rooms" would not bode well for Levity's future. Regardless of his/her identity, perhaps our hero will tell us what's so great about Levity of why - like Agextpert, he/she has returned after six years to save us all for ourselves. I hold one other AIM share - Reneuron - and on of the various boards (LSE, III etc.) there is a character called Fredd1eBoy. This apparently nice Chap has been promoting the share with unbelievable optimism and "the great breakthrough to our fortune has been just around the next RNS" for years now. It's just as ludicrous as some character coming back after six years or, to a lesser extent, dear old MTHead who hasn't said anything positive since 2011. The share price hasn't collapsed as a result of the patent application - as Timbo says this is not the first time this has happened. If anything, it has fallen back because the Wheat product has not yet arrived - that IS a disappointment to me but no reason to sell or worry. But the day I listen to purely positive Rampers or purely negative mischief makers (I do have other terms) is the day I go back to playing the Lottery. And where is BugOil when one needs it...
13/7/2016
06:52
wan: As Timbo points out you don't need a patent to commercialise your product, but you do need a patent to protect your product and stop others using it. Given the efforts deployed by the likes of Marks to have the patent refused, one assumes he has more than a personal vendetta with PI (given the management changes at PI), so we can assume he wants to use the product, which also tells us it's a great product. However, things have moved on! Whilst the likes of Marks has focused on the current technology, PI has been developing a new and improved technology and subsequently filed a patent application (which Marks cannot yet see!). Most readers will now know that the new technology has already launched as Fortalis, which importantly has already undergone extensive field testing. The results and data has resulted in the extension of Plant Impact's ongoing business relationship with Bayer CropScience, this technology validation via extensive field trials and Bayers further commitment (to both Fortalis and Veritas) says far more than Mark's can attempt to imply on here (or elsewhere). From the recent RNS - "This new foliar spray is Plant Impact's first formulated product to use the second generation of the Group's CaT(TM) technology, which has been developed over recent years, tested successfully in Argentina, Brazil and the United States and is subject to a pending patent application. " Obviously I expect PI to present further evidence (probably close to the 4 months time limit), which obviously could address the issues, especially as they have been precisely and clearly laid out, and at the very least, presenting further evidence will extend the process to the continued frustration of the likes of Mark's! In the meantime and in any regard, PI will continue to commercialise products that use the original technology, which as Timbo also highlights, is about more than what is contained in the patent itself e.g. actual in field testing and yield data and not to mention PI's secret formulation, which the patent does not reveal. Bayer's patent knowledge and indeed dedicated IP staff, will have also taken the situation into account before committing to both the current and new technology, and I would also draw readers attention to the following from the 'initial' commercial agreement with Bayer - "The parties have agreed to an initial, multi-year sales and production forecast and to various commercial and intellectual property responsibilities under the agreement. The financial details were not disclosed. " http://uk.advfn.com/stock-market/london/plant-impact-PIM/share-news/Plant-Impact-PLC-Commercial-Agreement/63457979 Notably then and six months later, PI announced a significant additional agreement with Bayer, which again actually says much more than the likes of Mark's can ever hope to say or imply. http://uk.advfn.com/stock-market/london/plant-impact-PIM/share-news/Plant-Impact-PLC-Significant-additional-Bayer-Crop/65497716 In short and in my view, efforts from the likes of Mark's will prove to have been ineffectual to PI's success!
02/6/2016
17:34
horace_h: Dear Me. We could always count on you to snipe and post only bad news when the share price was in the low teens and you've been quiet until the recent bouncing of the share price around the current value. As with most posters on this good board, Wan has been balanced and attended the Investor days when able. Similarly, Here and There has been a measure of both good and bad and acknowledged the need for "the next leg up" with the introduction of the wheat product as the required catalyst for another leg up in the share price. If Dr Adams and his team can't deliver then we'll all no doubt reconsider where the share price will go. Thus far they have delivered on all that they said they would and PIM is not just a one trick pony based on the lucrative Veritas product - Banzai being one obvious addition to the previous portfolio. You're entirely free to promote your enduringly negative view but I do not think that Wan deserved that snide comment.
10/5/2016
09:39
wan: Strange share price reaction, but one which has presented for another top-up opportunity for me.
22/3/2016
07:58
wan: Good coverage here - 21st Mar 2016, by Agrimoney.com Plant Impact receives Brazil boost - unlike larger ag sector peers Plant Impact, unlike larger peers, dodged the bullet of soft Brazilian agricultural input markets to report a near-doubling in half-year earnings, for a period which saw too the launch of a cocoa yield promoter. Market reaction The results were termed "strong" by broker Peel Hunt, which restated a "buy" rating on Plant Impact shares, on which it has a price target of 70p. "The deals with Bayer and Arysta provide the company with the opportunity to build material revenue streams in two key global crops," said Peel Hunt analyst Charles Hall. "There is potential for significant additional upside to our target [share] price as the company delivers on new products and markets." Full story - http://www.agrimoney.com/news/plant-impact-receives-brazil-boost---unlike-larger-ag-sector-peers--9437.html
04/2/2016
08:41
wan: In response to a few worries expressed on here, all I would say is that my personal horizons are too far out to worry about share price gyrations, which I have only ever used to top up, as opposed to top slice! The recent and extended deal with Bayer, to align PI's product pipeline in soy with the full solution of Bayer CropScience, looks to be hopefully only one, of what will prove to be several such deals. In other words, such deals for 'one' row crop are not based on flimsy scientific evidence or a weak pipeline, nor are such deals attached to attractive upfront and milestone payments if there is not good merit, indeed as this one is. Furthermore, PI's market approach (and potential), science and product pipeline are no doubt having an effect in attracting key individuals with excellent knowledge, experience and networks, the effect of which will no doubt be evident in the not too distant future. On top of this we have a management team that is very experienced and prudent and has delivered on the stated strategy. Keep in mind how disease resistance (cue Soybean Rust), not to mention patent expiry on existing products, can be overcome by combining products to very good effect both on and off the field! And then think how that could ultimately play out beyond Brazil's borders. Hence, I remain confident about PI's future and ultimate trajectory.
07/1/2016
07:53
wan: Pleased to see that the CEO made a 'measured and judicious' share purchase, which underscores my assessment that the share price fall was perhaps providing opportunity. I see no change to the, ultimately, upward trajectory in PI's business, the product pipeline and prospects are both healthy, and one assumes the CEO thinks so too!
31/12/2015
08:14
bigglesbingham: Hi Alan , your saying Brazil concerns you but results from Brazil are only just filtering into the share price. It's not as though share price has been reliant on Brazil for a number of years and profits just starting to drop off. I think the key here is the quality of management and research appointments . Dyor but their expertise is unquestioned and top managements ultimate remuneration is linked to share price performance .
05/10/2015
06:20
wan: Watching the small picture (daily volume and/or share price) risks taking ones eye off of the big picture and ultimate trend - October 4, 2015 11:51 am Land the size of Great Britain needed to feed Chinese meat demand Emiko Terazono Agricultural land equivalent to the size of England, Scotland and Wales, will be needed to meet the demand of future Chinese meat consumption, as the portion of protein in diets steadily increases, according to a report. The average Chinese eats about 57kg of meat a year, up by almost a quarter from 2003, when consumption totalled 46kg. This is expected to rise to 74kg in the next decade, pushing up grains and soyabean demand by 94m tonnes for livestock from the current overall usage of 650m tonnes. The increase in feed demand is also coming from the rest of Asia, where rising incomes are changing diets with increasing meat consumption. Aurelia Britsch, senior commodities analyst at BMI Research, said: “Trade in agricultural products in the Asia-Pacific region is set to soar in the coming years. Full story FT.Com - http://www.ft.com/cms/s/0/478ac130-6847-11e5-a57f-21b88f7d973f.html#axzz3nf5o4wgp
31/7/2015
15:12
cisk: Hi Wan tbh I'm not really that worked up about the incentives - if one stayed away from companies that gave 'large' rewards to CEOs for performance, then you'd miss out on some great performances over the years. D S Smith for example has more than doubled in a handful of years, and there was great disquiet about CEO packages there I seem to recall. Similar at WPP - which over several decades went from being a tiny wire making company to one of the world's biggest advertising conglomerates. Anyway I digress - as long as the share price continues its upward momentum during the period allowed for option vesting, I'm happy. It's when option prices are re-based downwards to reflect poor performance (in terms of share price, management and / or profits) I tend to sell. I would hope that this continues on its independent way for some time yet; I've only dipped my toe in the water and will continue slowly building a stake. I'm happy being patient and taking a 5 year view on this one - realise that most want a quick return (who wouldn't after all!) but quite happy to sit in there for longer-term gains.
Plant Impact share price data is direct from the London Stock Exchange
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:34 V: D:20161204 01:58:20